Literature DB >> 12892229

Preoperative proton-MR spectroscopy of gliomas--correlation with quantitative nuclear morphology in surgical specimen.

Reinhold Nafe1, Sebastian Herminghaus, Peter Raab, Sabine Wagner, Ulrich Pilatus, Berthold Schneider, Wolfgang Schlote, Friedhelm Zanella, Heinrich Lanfermann.   

Abstract

A comparison between data from proton-MR spectroscopy (1HMRS) and quantitative histomorphology of tumor cell nuclei in gliomas has not been reported up to now. Therefore, the question must be answered, if there are any significant correlations between histomorphology of gliomas and quantitative data from 1HMRS concerning tissue metabolites. Surgical glioma specimen (glioblastomas, astrocytomas, oligodendrogliomas) from 46 patients with tumor grades II-IV according to WHO have been evaluated by means of a digital image analysis system using Ki-67-immunostained paraffin sections. Nuclear density, Ki-67-proliferation index, nuclear area and shape variables (roundness factor, Fourier-amplitudes) have been determined from 200 randomly selected tumor cell nuclei in each tumor specimen. These data have been correlated with preoperative data from 1HMRS. A positive correlation between Fourier-amplitudes, choline peak and lipide peak was observed, as well as a negative correlation between these variables and the nuclear roundness factor. This result indicates higher choline and lipide peaks with increasing irregularity of nuclear outlines. Proliferation index Ki-67 was positively correlated with the lipide peak, nuclear density showed a positive correlation with the choline peak. Glioblastomas (n = 29) showed an additional positive correlation between mean nuclear size and total creatine. Anaplastic gliomas (n = 12) showed a positive correlation between lactate peak and the standard deviation of the nuclear roundness factor. Further multivariate analyses have shown, that for the present collective of 46 cases, histometric variables have a higher significance than spectroscopic data for the differentiation of the different tumor grades. These results verify a significant correlation between preoperative data from 1HMRS and histomorphology of tumor cell nuclei in gliomas, supporting the biological significance of both histomorphometry and 1HMRS for the evaluation of these tumors.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12892229     DOI: 10.1023/a:1024249232454

Source DB:  PubMed          Journal:  J Neurooncol        ISSN: 0167-594X            Impact factor:   4.130


  47 in total

Review 1.  Magnetic resonance spectroscopy and imaging methods for measuring tumour and tissue oxygenation.

Authors:  C L McCoy; D J McIntyre; S P Robinson; E O Aboagye; J R Griffiths
Journal:  Br J Cancer Suppl       Date:  1996-07

2.  Clinical impact of MR spectroscopy when MR imaging is indeterminate for pediatric brain tumors.

Authors:  J F Norfray; T Tomita; S E Byrd; B D Ross; P A Berger; R S Miller
Journal:  AJR Am J Roentgenol       Date:  1999-07       Impact factor: 3.959

3.  Magnetic resonance spectroscopy (MRS) in the evaluation of pediatric brain tumors, Part II: Clinical analysis.

Authors:  S E Byrd; T Tomita; P S Palka; C F Darling; J P Norfray; J Fan
Journal:  J Natl Med Assoc       Date:  1996-11       Impact factor: 1.798

4.  Variation of post-treatment H-MRSI choline intensity in pediatric gliomas.

Authors:  J A Lazareff; R K Gupta; J Alger
Journal:  J Neurooncol       Date:  1999-02       Impact factor: 4.130

5.  Detection of locally recurrent prostate cancer after cryosurgery: evaluation by transrectal ultrasound, magnetic resonance imaging, and three-dimensional proton magnetic resonance spectroscopy.

Authors:  F Parivar; H Hricak; K Shinohara; J Kurhanewicz; D B Vigneron; S J Nelson; P R Carroll
Journal:  Urology       Date:  1996-10       Impact factor: 2.649

6.  Efficacy of proton magnetic resonance spectroscopy in clinical decision making for patients with suspected malignant brain tumors.

Authors:  A Lin; S Bluml; A N Mamelak
Journal:  J Neurooncol       Date:  1999       Impact factor: 4.130

7.  MR spectroscopy in gliomatosis cerebri.

Authors:  M Bendszus; M Warmuth-Metz; R Klein; R Burger; C Schichor; J C Tonn; L Solymosi
Journal:  AJNR Am J Neuroradiol       Date:  2000-02       Impact factor: 3.825

8.  In vivo proton MR spectroscopy of human gliomas: definition of metabolic coordinates for multi-dimensional classification.

Authors:  G Hagberg; A P Burlina; I Mader; W Roser; E W Radue; J Seelig
Journal:  Magn Reson Med       Date:  1995-08       Impact factor: 4.668

9.  Localized 1H NMR spectroscopy in fifty cases of newly diagnosed intracranial tumors.

Authors:  P Demaerel; K Johannik; P Van Hecke; C Van Ongeval; S Verellen; G Marchal; G Wilms; C Plets; J Goffin; F Van Calenbergh
Journal:  J Comput Assist Tomogr       Date:  1991 Jan-Feb       Impact factor: 1.826

10.  Pediatric low-grade gliomas: prognosis with proton magnetic resonance spectroscopic imaging.

Authors:  J A Lazareff; K H Bockhorst; J Curran; C Olmstead; J R Alger
Journal:  Neurosurgery       Date:  1998-10       Impact factor: 4.654

View more
  12 in total

Review 1.  A systematic literature review of magnetic resonance spectroscopy for the characterization of brain tumors.

Authors:  W Hollingworth; L S Medina; R E Lenkinski; D K Shibata; B Bernal; D Zurakowski; B Comstock; J G Jarvik
Journal:  AJNR Am J Neuroradiol       Date:  2006-08       Impact factor: 3.825

2.  Whole-brain spectroscopic MRI biomarkers identify infiltrating margins in glioblastoma patients.

Authors:  James S Cordova; Hui-Kuo G Shu; Zhongxing Liang; Saumya S Gurbani; Lee A D Cooper; Chad A Holder; Jeffrey J Olson; Brad Kairdolf; Eduard Schreibmann; Stewart G Neill; Constantinos G Hadjipanayis; Hyunsuk Shim
Journal:  Neuro Oncol       Date:  2016-03-15       Impact factor: 12.300

3.  Proton magnetic resonance spectroscopy in childhood brainstem lesions.

Authors:  L Porto; E Hattingen; U Pilatus; M Kieslich; B Yan; D Schwabe; F E Zanella; H Lanfermann
Journal:  Childs Nerv Syst       Date:  2006-09-16       Impact factor: 1.475

4.  Prediction of anaplastic transformation in low-grade oligodendrogliomas based on magnetic resonance spectroscopy and 1p/19q codeletion status.

Authors:  Pierre Bourdillon; Chadi Hlaihel; Jacques Guyotat; Laurent Guillotton; Jérôme Honnorat; François Ducray; François Cotton
Journal:  J Neurooncol       Date:  2015-02-26       Impact factor: 4.130

5.  Evaluation of invasiveness of astrocytoma using 1H-magnetic resonance spectroscopy: correlation with expression of matrix metalloproteinase-2.

Authors:  Kai Zhang; Chuanfu Li; Ying Liu; Li Li; Xiangxing Ma; Xiangshui Meng; Dechao Feng
Journal:  Neuroradiology       Date:  2007-09-01       Impact factor: 2.804

6.  MR spectroscopy in the evaluation of recurrent contrast-enhancing lesions in the posterior fossa after tumor treatment.

Authors:  P Weybright; P Maly; D Gomez-Hassan; C Blaesing; P C Sundgren
Journal:  Neuroradiology       Date:  2004-04-23       Impact factor: 2.804

7.  Proton magnetic resonance spectroscopy predicts proliferative activity in diffuse low-grade gliomas.

Authors:  Remy Guillevin; Carole Menuel; Hugues Duffau; Michel Kujas; Laurent Capelle; Agnès Aubert; Sophie Taillibert; Ahmed Idbaih; Joan Pallud; Giovanni Demarco; Robert Costalat; Khê Hoang-Xuan; Jacques Chiras; Jean-Noel Vallée
Journal:  J Neurooncol       Date:  2007-12-28       Impact factor: 4.130

8.  Predictive value of multimodality MRI using conventional, perfusion, and spectroscopy MR in anaplastic transformation of low-grade oligodendrogliomas.

Authors:  Chadi Hlaihel; Laurent Guilloton; Jacques Guyotat; Nathalie Streichenberger; Jerome Honnorat; François Cotton
Journal:  J Neurooncol       Date:  2009-08-29       Impact factor: 4.130

9.  Absolute choline concentration measured by quantitative proton MR spectroscopy correlates with cell density in meningioma.

Authors:  Qiang Yue; Yasushi Shibata; Tomonori Isobe; Izumi Anno; Hiraku Kawamura; Qi-Yong Gong; Akira Matsumura
Journal:  Neuroradiology       Date:  2008-11-11       Impact factor: 2.804

10.  A systematic pipeline for the objective comparison of whole-brain spectroscopic MRI with histology in biopsy specimens from grade III glioma.

Authors:  J Scott Cordova; Saumya S Gurbani; Jeffrey J Olson; Zhongxing Liang; Lee A D Cooper; Hui-Kuo G Shu; Eduard Schreibmann; Stewart G Neill; Constantinos G Hadjipanayis; Chad A Holder; Hyunsuk Shim
Journal:  Tomography       Date:  2016-06
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.